3SBio acquires Sirton Pharmaceuticals

China-based biotechnology company 3SBio has acquired the entire share capital of Italian group Sirton Pharmaceuticals. more »

Jan 29, 2015 10:06 AM News

Life Sciences Minister on DNA and data

George Freeman MP, the Minister for Life Sciences, will give a keynote address for the pharma sector at an event which will tackle the future of DNA and data in healthcare. more »

Jan 26, 2015 11:00 AM News

Big growth for drug/device combinations

The global drug/device combination products market is expected to witness significant growth in the years to come. more »

Jan 20, 2015 11:34 AM News

Double digit growth for protein microarrays

The market for microarrays used to study the workings of proteins are in great demand, according to Kalorama Information. more »

Jan 15, 2015 12:13 PM News

Packaging Innovations back with a bang

Packaging Innovations returns to the NEC, Birmingham on 25 and 26 February 2015. more »

Jan 15, 2015 12:00 AM

Shire to acquire NPS Pharma in gastrointestinal and rare disease knowledge-share

Shire is to acquire all outstanding shares of NPS Pharmaceuticals for $46.00 per share in cash, for a total consideration of approximately $5.2 billion. more »

Jan 12, 2015 11:47 AM News

MGB Biopharma talks anti-infectives for antibiotic resistance

MGB Biopharma, a biopharmaceutical company developing a new class of anti-infectives, provides an update on its performance for 2014. more »

Jan 12, 2015 9:40 AM News

Catalent appoints general managers for clinical supply services

Catalent Pharma Solutions has appointed two General Managers to oversee key Clinical Supply Services facilities in its European network. more »

Jan 8, 2015 1:06 PM News

Sciformix to enter European pharma sector with UK office

Scientific process organisation Sciformix Corporation has opened a new office in Manchester, UK, marking its entry to the European market. more »

Jan 7, 2015 9:10 AM News

Novartis goes digital with ‘Trials of the Future’

Novartis will launch a new initiative, ‘Trials of the Future’, to digitally connect and aggregate medical device data during clinical trials. more »

Jan 6, 2015 9:29 AM News

Hovione gets green light following FDA inspection

Manufacturer Hovione has passed an FDA Pre-Approval Inspection at its plant in Loures, Portugal, covering two NDA filings. more »

Jan 5, 2015 2:06 PM News

Gelatin could pave delivery route to the brain

University of Illinois researchers, as well as a team in South Korea, have presented new findings that claim to show that gelatin nanoparticles could be used for drug delivery to the brain. more »

Jan 5, 2015 10:50 AM News

Lilly closes Novartis Animal Health deal

After several months spent gaining approvals, the acquisition which sees Eli Lilly expand significantly has now completed. more »

Jan 2, 2015 2:48 PM News

Regulatory affairs: Guiding light

Dr Parvinder Punia, senior regulatory affairs manager, ELC Group, discusses the use of guidelines in drug development more »

Dec 23, 2014 9:49 AM Opinion

Evotec and Sanofi form drug discovery agreement

Evotec has entered into exclusive negotiations with Sanofi on a major multi-component strategic alliance over the next five years. more »

Dec 10, 2014 10:08 AM News

Sepha scoops innovators award

Northern Ireland-based pharmaceuticals packaging machinery manufacturer Sepha has won the award for Excellence in Innovation from the UK Chamber of Commerce. more »

Dec 9, 2014 11:36 AM News

Evgen Pharma to float on stock exchange

Evgen Pharma plc, a clinical stage drug development company active in cancer and neurological treatments has announced its intention to join the AIM market of the London Stock Exchange by way of a Placing to raise up to £20 million. more »

Dec 4, 2014 4:03 PM News

Unilife/Sanofi wearables deal ‘unprecedented’, says Shortall

Unilife’s agreement with Sanofi to be the sole provider of cartridge based wearable injectors is ‘unprecedented’, according to Alan Shortall, Chairman and Chief Executive Officer at the firm. more »

Dec 1, 2014 4:43 PM News

Isis and AstraZeneca team up on antisense oligonucleotides

Isis Pharmaceuticals and AstraZeneca are teaming up to develop delivery methods for antisense oligonucleotides — short, single strands of DNA or RNA molecules. more »

Nov 26, 2014 2:44 PM News

HIV drug pioneer Raymond Schinazi honoured by industry

Dr Raymond F Schinazi has been awarded the Distinguished Scientific Achievement Award by the American Liver Foundation. more »

Nov 25, 2014 2:55 PM News

Medical Expo

Built with Metro Publisher™